These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11758138)

  • 21. Comparative tolerability of pharmacological treatments for patent ductus arteriosus.
    Hammerman C; Kaplan M
    Drug Saf; 2001; 24(7):537-51. PubMed ID: 11444725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variation and comparative effectiveness of patent ductus arteriosus pharmacotherapy in extremely low birth weight infants.
    ElHassan NO; Bird TM; King AJ; Ambadwar PB; Jaquiss RD; Kaiser JR; Robbins JM
    J Neonatal Perinatal Med; 2014 Jan; 7(3):229-35. PubMed ID: 25322995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of ibuprofen versus indomethacin for the treatment of patent ductus arteriosus in the preterm infant: reviewing the evidence.
    Donze A; Smith JR; Bryowsky K
    Neonatal Netw; 2007; 26(3):187-95. PubMed ID: 17521065
    [No Abstract]   [Full Text] [Related]  

  • 24. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants.
    Jasani B; Mitra S; Shah PS
    Cochrane Database Syst Rev; 2022 Dec; 12():CD010061. PubMed ID: 36519620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ibuprofen--a new application for pharmacological closure of patent ductus arteriosus in preterm infants. Preliminary report].
    Adamska E
    Med Wieku Rozwoj; 2000; 4(2 Suppl 3):65-71. PubMed ID: 11328971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of patent ductus arteriosus: indomethacin or ibuprofen?
    Sekar KC; Corff KE
    J Perinatol; 2008 May; 28 Suppl 1():S60-2. PubMed ID: 18446180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular endothelial growth factor polymorphism rs2010963 status does not affect patent ductus arteriosus incidence or cyclooxygenase inhibitor treatment success in preterm infants.
    Sallmon H; Aydin T; Hort S; Kubinski A; Bode C; Klippstein T; Endesfelder S; Bührer C; Koehne P
    Cardiol Young; 2019 Jul; 29(7):893-897. PubMed ID: 31218973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Shah SS
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD004213. PubMed ID: 31222841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patent ductus arteriosus in premature neonates.
    Mezu-Ndubuisi OJ; Agarwal G; Raghavan A; Pham JT; Ohler KH; Maheshwari A
    Drugs; 2012 May; 72(7):907-16. PubMed ID: 22564132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of oral ibuprofen with oral indomethacin for PDA closure in Indian preterm neonates: a randomized controlled trial.
    Yadav S; Agarwal S; Maria A; Dudeja A; Dubey NK; Anand P; Yadav DK
    Pediatr Cardiol; 2014 Jun; 35(5):824-30. PubMed ID: 24435507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indomethacin for symptomatic patent ductus arteriosus in preterm infants.
    Evans P; O'Reilly D; Flyer JN; Soll R; Mitra S
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013133. PubMed ID: 33448032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of patent ductus arteriosus: indomethacin or ibuprofen?
    Linder N; Bello R; Hernandez A; Rosen C; Birk E; Sirota L; Pushkov Y; Klinger G
    Am J Perinatol; 2010 May; 27(5):399-404. PubMed ID: 20013578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
    Shah SS; Ohlsson A
    Cochrane Database Syst Rev; 2006 Jan; (1):CD004213. PubMed ID: 16437478
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Rooney SR; Shelton EL; Aka I; Shaffer CM; Clyman RI; Dagle JM; Ryckman K; Lewis TR; Reese J; Van Driest SL; Kannankeril PJ
    Pharmacogenomics; 2019 Aug; 20(13):939-946. PubMed ID: 31486736
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants.
    Su PH; Chen JY; Su CM; Huang TC; Lee HS
    Pediatr Int; 2003 Dec; 45(6):665-70. PubMed ID: 14651538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of therapeutics used in management of patent ductus arteriosus in preterm infants.
    Oncel MY; Erdeve O
    Curr Drug Saf; 2015; 10(2):106-12. PubMed ID: 25323589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ibuprofen and patent ductus arteriosus.
    Clyman RI
    N Engl J Med; 2000 Sep; 343(10):728-30. PubMed ID: 10974138
    [No Abstract]   [Full Text] [Related]  

  • 38. Association between changes in urine output and successful indomethacin treatment for patent ductus arteriosus in preterm neonates.
    Louis D; Dey A; Jain A
    J Paediatr Child Health; 2021 Apr; 57(4):554-558. PubMed ID: 33233014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence-based use of indomethacin and ibuprofen in the neonatal intensive care unit.
    Johnston PG; Gillam-Krakauer M; Fuller MP; Reese J
    Clin Perinatol; 2012 Mar; 39(1):111-36. PubMed ID: 22341541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. To Feed or Not to Feed: A Critical Overview of Enteral Feeding Management and Gastrointestinal Complications in Preterm Neonates with a Patent Ductus Arteriosus.
    Martini S; Aceti A; Galletti S; Beghetti I; Faldella G; Corvaglia L
    Nutrients; 2019 Dec; 12(1):. PubMed ID: 31892190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.